Ameriprise Financial assumed coverage on shares of Tenet Healthcare (NYSE: THC) in a research note issued to investors on Friday. The firm issued a buy rating on the stock.

Tenet Healthcare (NYSE: THC) traded up 1.18% on Friday, hitting $44.73. Tenet Healthcare has a 1-year low of $17.24 and a 1-year high of $45.00. The stock’s 50-day moving average is currently $40.22. The company has a market cap of $4.665 billion and a price-to-earnings ratio of 34.11.

Several other analysts have also recently commented on the stock. Analysts at Zacks downgraded shares of Tenet Healthcare from an outperform rating to a neutral rating in a research note to investors on Thursday, March 14th. They now have a $46.00 price target on the stock. Separately, analysts at UBS AG raised their price target on shares of Tenet Healthcare from $41.00 to $46.00 in a research note to investors on Tuesday, March 12th. They now have a neutral rating on the stock. Finally, analysts at Deutsche Bank reiterated a buy rating on shares of Tenet Healthcare in a research note to investors on Friday, March 8th. They now have a $46.00 price target on the stock.

Twelve equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus target price of $39.31.

Tenet Healthcare Corporation, and its subsidiaries (NYSE: THC) is an investor-owned health care services company whose subsidiaries and affiliates own and operate acute care hospitals, ambulatory surgery centers, diagnostic imaging centers and related health care facilities.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.